-
2
-
-
0016776320
-
Increase in serum cholesterol during phenytoin treatment
-
Pelkonen R., Fogelholm R., Nikkila EA Increase in serum cholesterol during phenytoin treatment. Br Med J. 1975;4:85.
-
(1975)
Br Med J.
, vol.4
, pp. 85
-
-
Pelkonen, R.1
Fogelholm, R.2
Nikkila, E.A.3
-
3
-
-
0017877427
-
Increase of serum high density lipoprotein in phenytoin users
-
Nikkilä EA, Kaste M., Ehnholm C., Viikari J. Increase of serum high density lipoprotein in phenytoin users. Br Med J. 1978;2:99.
-
(1978)
Br Med J.
, vol.2
, pp. 99
-
-
Nikkilä, E.A.1
Kaste, M.2
Ehnholm, C.3
Viikari, J.4
-
4
-
-
0018625627
-
Effect of phenobarbitone on plasma apolipoprotein B and plasma high-density-lipoprotein cholesterol in normal subjects
-
Durrington PN Effect of phenobarbitone on plasma apolipoprotein B and plasma high-density-lipoprotein cholesterol in normal subjects. Clin Sci. 1979;56:501-504.
-
(1979)
Clin Sci.
, vol.56
, pp. 501-504
-
-
Durrington, P.N.1
-
5
-
-
0018687569
-
Changes in serum triglycerides and cholesterol levels during long term phenytoin treatment for epilepsy
-
Luoma PV, Reunanen MI, Sotaniemi EA Changes in serum triglycerides and cholesterol levels during long term phenytoin treatment for epilepsy. Acta Med Scand. 1979;206:229-231.
-
(1979)
Acta Med Scand.
, vol.206
, pp. 229-231
-
-
Luoma, P.V.1
Reunanen, M.I.2
Sotaniemi, E.A.3
-
6
-
-
0026437718
-
Carbamazepine-induced increase in total serum cholesterol: Clinical and theoretical implications
-
Brown DW, Ketter TA, Crumlish J., Post RM Carbamazepine-induced increase in total serum cholesterol: Clinical and theoretical implications. J Clin Psychopharmacol. 1992;12:431-437.
-
(1992)
J Clin Psychopharmacol.
, vol.12
, pp. 431-437
-
-
Brown, D.W.1
Ketter, T.A.2
Crumlish, J.3
Post, R.M.4
-
8
-
-
0032934981
-
Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: A gender-related study
-
Sudhop T., Bauer J., Elger CE, Von Bergmann K. Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: A gender-related study. Epilepsia. 1999;40:480-484.
-
(1999)
Epilepsia.
, vol.40
, pp. 480-484
-
-
Sudhop, T.1
Bauer, J.2
Elger, C.E.3
Von Bergmann, K.4
-
9
-
-
0025802072
-
Serum lipids, lipoprotein and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital
-
Calandre EP, Rodriquez-Lopez C., Blazquez A., Cano D. Serum lipids, lipoprotein and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital. Acta Neurol Scand. 1991;83:250-253.
-
(1991)
Acta Neurol Scand.
, vol.83
, pp. 250-253
-
-
Calandre, E.P.1
Rodriquez-Lopez, C.2
Blazquez, A.3
Cano, D.4
-
10
-
-
10744231478
-
European guidelines on cardiovascular disease and prevention in clinical practice
-
De Backer G., Ambrosioni E., Borch-Johnsen K., et al. European guidelines on cardiovascular disease and prevention in clinical practice. Atherosclerosis. 2003;171:145-155.
-
(2003)
Atherosclerosis.
, vol.171
, pp. 145-155
-
-
De Backer, G.1
Ambrosioni, E.2
Borch-Johnsen, K.3
-
11
-
-
3142729178
-
Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines
-
Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation. 2004;110:227-239.
-
(2004)
Circulation.
, vol.110
, pp. 227-239
-
-
Grundy, S.M.1
Cleeman, J.I.2
Merz, C.N.3
-
12
-
-
1242340399
-
Apolipoprotein B and apolipoprotein A-I: Risk indicators of coronary heart disease and targets for lipid-modifying therapy
-
Walldius G., Jungner I. Apolipoprotein B and apolipoprotein A-I: Risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Intern Med. 2004;255:188-205.
-
(2004)
J Intern Med.
, vol.255
, pp. 188-205
-
-
Walldius, G.1
Jungner, I.2
-
13
-
-
33646254885
-
Apolipoproteins as markers and managers of coronary risk
-
Chan DC, Watts GF Apolipoproteins as markers and managers of coronary risk. QJM. 2006;99:277-287.
-
(2006)
QJM.
, vol.99
, pp. 277-287
-
-
Chan, D.C.1
Watts, G.F.2
-
14
-
-
4544289560
-
Lipoprotein transport in the metabolic syndrome: Methodological aspects of stable isotope kinetic studies
-
Chan DC, Barrett PH, Watts GF Lipoprotein transport in the metabolic syndrome: Methodological aspects of stable isotope kinetic studies. Clin Sci. 2004;107:221-232.
-
(2004)
Clin Sci.
, vol.107
, pp. 221-232
-
-
Chan, D.C.1
Barrett, P.H.2
Watts, G.F.3
-
15
-
-
0024317220
-
Proposal for revised classification of epilepsies and epileptic syndromes
-
Commission on Classification and Terminology of the International League Against Epilepsy
-
Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989;30:389-399.
-
(1989)
Epilepsia.
, vol.30
, pp. 389-399
-
-
-
16
-
-
0034974442
-
Effect of antiepileptic drugs on plasma lipoprotein (a) and other lipid levels in childhood
-
Aynaci FM, Orhan F., Orem A., et al. Effect of antiepileptic drugs on plasma lipoprotein (a) and other lipid levels in childhood. J Child Neurol. 2001;16:367-369.
-
(2001)
J Child Neurol.
, vol.16
, pp. 367-369
-
-
Aynaci, F.M.1
Orhan, F.2
Orem, A.3
-
17
-
-
0029020273
-
Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy
-
Eiris JM, Lojo S., Del Rio MC, et al. Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy. Neurology. 1995;45:1155-1157.
-
(1995)
Neurology.
, vol.45
, pp. 1155-1157
-
-
Eiris, J.M.1
Lojo, S.2
Del Rio, M.C.3
-
18
-
-
0022344052
-
Effect of anticonvulsant drugs on plasma total cholesterol, high-density lipoprotein cholesterol, and apolipoproteins A and B in children with epilepsy
-
Reddy MN Effect of anticonvulsant drugs on plasma total cholesterol, high-density lipoprotein cholesterol, and apolipoproteins A and B in children with epilepsy. Proc Soc Exp Biol Med. 1985;180:359-363.
-
(1985)
Proc Soc Exp Biol Med.
, vol.180
, pp. 359-363
-
-
Reddy, M.N.1
-
19
-
-
0020362982
-
Relationship between plasma high density lipoprotein cholesterol and anticonvulsant levels in epileptics
-
Luoma PV, Myllyla VV, Hokkanen E. Relationship between plasma high density lipoprotein cholesterol and anticonvulsant levels in epileptics. J Cardiovasc Pharmacol. 1982;4:1024-1027.
-
(1982)
J Cardiovasc Pharmacol.
, vol.4
, pp. 1024-1027
-
-
Luoma, P.V.1
Myllyla, V.V.2
Hokkanen, E.3
-
20
-
-
1942534724
-
The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy
-
Nikolaos T., Stylianos G., Chryssoula N., et al. The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy. Med Sci Monit. 2004;10:MT50-MT52.
-
(2004)
Med Sci Monit.
, vol.10
-
-
Nikolaos, T.1
Stylianos, G.2
Chryssoula, N.3
-
21
-
-
0026803340
-
Total cholesterol, high density lipoprotein cholesterol and triglycerides in children receiving antiepileptic drugs
-
Franzoni E., Govoni M., D'addato S., et al. Total cholesterol, high density lipoprotein cholesterol and triglycerides in children receiving antiepileptic drugs. Epilepsia. 1992;33:932-935.
-
(1992)
Epilepsia.
, vol.33
, pp. 932-935
-
-
Franzoni, E.1
Govoni, M.2
D'addato, S.3
-
22
-
-
0030872973
-
Serum lipids in epileptic children treated with carbamazepine and valproate
-
Sozuer DT, Atakil D., Dogu O., et al. Serum lipids in epileptic children treated with carbamazepine and valproate. Eur J Pediatr. 1997;156:565-567.
-
(1997)
Eur J Pediatr.
, vol.156
, pp. 565-567
-
-
Sozuer, D.T.1
Atakil, D.2
Dogu, O.3
-
23
-
-
0030788486
-
Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants
-
Verrotti A., Domizio S., Angelozzi B., et al. Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants. J Paediatr Child Health. 1997;33:242-245.
-
(1997)
J Paediatr Child Health.
, vol.33
, pp. 242-245
-
-
Verrotti, A.1
Domizio, S.2
Angelozzi, B.3
-
24
-
-
21844436521
-
Growth and lipid metabolism in girls and young women with epilepsy during pubertal maturation
-
Mikkonen K., Knip M., Pakarinen AJ, et al. Growth and lipid metabolism in girls and young women with epilepsy during pubertal maturation. Epilepsia. 2005;46:1114-1120.
-
(2005)
Epilepsia.
, vol.46
, pp. 1114-1120
-
-
Mikkonen, K.1
Knip, M.2
Pakarinen, A.J.3
-
25
-
-
0035704409
-
Serum lipid changes during anticonvulsive treatment in epileptic children
-
Yilmaz E., Dosan Y., Gurgoze MK, Gungor S. Serum lipid changes during anticonvulsive treatment in epileptic children. Acta Neurol Belg. 2001;101:217-220.
-
(2001)
Acta Neurol Belg.
, vol.101
, pp. 217-220
-
-
Yilmaz, E.1
Dosan, Y.2
Gurgoze, M.K.3
Gungor, S.4
-
26
-
-
25144449201
-
Effects of carbamazepine on serum lipids and liver function tests
-
Aggarwal A., Kumar M., Faridi MM Effects of carbamazepine on serum lipids and liver function tests. Indian pediatr. 2005;42:913-918.
-
(2005)
Indian Pediatr.
, vol.42
, pp. 913-918
-
-
Aggarwal, A.1
Kumar, M.2
Faridi, M.M.3
-
27
-
-
0343526753
-
The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy
-
Eiris J., Novo-Rodriguez MI, Del Rio M., et al. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy. Epilepsy Res. 2000;41:1-7.
-
(2000)
Epilepsy Res.
, vol.41
, pp. 1-7
-
-
Eiris, J.1
Novo-Rodriguez, M.I.2
Del Rio, M.3
-
28
-
-
13844297622
-
Serum lipid levels during carbamazepine therapy in epileptic children
-
Mahmoudian T., Iranpour R., Messri N. Serum lipid levels during carbamazepine therapy in epileptic children. Epilepsy Behav. 2005;6:257-259.
-
(2005)
Epilepsy Behav.
, vol.6
, pp. 257-259
-
-
Mahmoudian, T.1
Iranpour, R.2
Messri, N.3
-
29
-
-
0027336516
-
Changes of serum lipid patterns during long-term anticonvulsive treatment
-
Zeitlhofer J., Doppelbauer A., Tribl G., et al. Changes of serum lipid patterns during long-term anticonvulsive treatment. Clin Investig. 1993;71:574-578.
-
(1993)
Clin Investig.
, vol.71
, pp. 574-578
-
-
Zeitlhofer, J.1
Doppelbauer, A.2
Tribl, G.3
-
30
-
-
0042415497
-
Effect of long term carbamazepine therapy on serum lipids, vitamin B12 and folic acid level in children
-
Dada G., Caksen H., Içaasiolu D. Effect of long term carbamazepine therapy on serum lipids, vitamin B12 and folic acid level in children. J Pediatr Endocrinol Metab. 2003;16:193-196.
-
(2003)
J Pediatr Endocrinol Metab.
, vol.16
, pp. 193-196
-
-
Dada, G.1
Caksen, H.2
Içaasiolu, D.3
-
31
-
-
33646874537
-
Effect of antiepileptic drugs on plasma lipids, lipoprotein(a) and liver enzymes
-
Sonmez FM, Demir E., Orem A., et al. Effect of antiepileptic drugs on plasma lipids, lipoprotein(a) and liver enzymes. J Child Neurol. 2006;21:70-74.
-
(2006)
J Child Neurol.
, vol.21
, pp. 70-74
-
-
Sonmez, F.M.1
Demir, E.2
Orem, A.3
-
32
-
-
33750348150
-
Serum lipid profile in children receiving anti-epileptic drug monotherapy: Is it atherogenic ?
-
Tekgul H., Demir N., Gokben S. Serum lipid profile in children receiving anti-epileptic drug monotherapy: Is it atherogenic ? J Pediatr Endocrinol Metab. 2006;19:1151-1155.
-
(2006)
J Pediatr Endocrinol Metab.
, vol.19
, pp. 1151-1155
-
-
Tekgul, H.1
Demir, N.2
Gokben, S.3
-
33
-
-
0030076129
-
The effects of phenobarbital, valproic acid and carbamazepine on the serum lipids and lipoproteins in a pediatric population
-
de Juan Frigola J., Crespo Hernández M., Braga Hernández S. The effects of phenobarbital, valproic acid and carbamazepine on the serum lipids and lipoproteins in a pediatric population. An Esp Pediatr. 1996;44:133-138.
-
(1996)
An Esp Pediatr.
, vol.44
, pp. 133-138
-
-
de Juan Frigola, J.1
Crespo Hernández, M.2
Braga Hernández, S.3
-
34
-
-
0032214872
-
Serum lipids and lipoproteins in patients treated with antiepileptic drugs
-
Verrotti A., Basciani F., Domizio S., et al. Serum lipids and lipoproteins in patients treated with antiepileptic drugs. Pediatr Neurol. 1998;19:364-367.
-
(1998)
Pediatr Neurol.
, vol.19
, pp. 364-367
-
-
Verrotti, A.1
Basciani, F.2
Domizio, S.3
-
35
-
-
54549095559
-
Valproate biotransformation
-
In: Levy RH, Dreifuss FE, Mattson RH, Meldrum BS, Penry JK, eds. New York, NY: Raven Press
-
Kuhara-Baillie TA, Rettenmeier AW Valproate biotransformation. In: Levy RH, Dreifuss FE, Mattson RH, Meldrum BS, Penry JK, eds. Antiepileptic Drugs. New York, NY: Raven Press; 1989: 6014.
-
(1989)
Antiepileptic Drugs
, pp. 6014
-
-
Kuhara-Baillie, T.A.1
Rettenmeier, A.W.2
-
36
-
-
0002447086
-
Lipids, lipoproteins, and apolipoproteins
-
In: Burlis AC, Ashwood RE, eds. Philadelphia, PA: WB Saunders Company
-
Rifai N., Bachorik S., Albers J. Lipids, lipoproteins, and apolipoproteins. In: Burlis AC, Ashwood RE, eds. Tietz Textbook of Clinical Biochemistry. Philadelphia, PA: WB Saunders Company; 1999: 809-860.
-
(1999)
Tietz Textbook of Clinical Biochemistry
, pp. 809-860
-
-
Rifai, N.1
Bachorik, S.2
Albers, J.3
-
37
-
-
0034456308
-
Plasma apolipoprotein A-I and B concentrations in growth-retarded fetuses: A link between low birth weight and adult atherosclerosis
-
Radunovic N., Kuczynski E., Rosen T., et al. Plasma apolipoprotein A-I and B concentrations in growth-retarded fetuses: A link between low birth weight and adult atherosclerosis. J Clin Endocrinol Metab. 2000;85:85-88.
-
(2000)
J Clin Endocrinol Metab.
, vol.85
, pp. 85-88
-
-
Radunovic, N.1
Kuczynski, E.2
Rosen, T.3
|